Stay updated on Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA site-wide NIH notice explains the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check33 days agoChange DetectedThe ClinicalTrials.gov site revision shown in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check54 days agoChange DetectedA new latest revision label, v3.7.0, has been added to the record history, while the previous label v3.6.6 has been removed.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now displays the latest revision label 'Revision: v3.6.6', replacing the previous 'Revision: v3.6.5'. This reflects an update to the page's release/version information in the history view.SummaryDifference0.0%

- Check89 days agoChange DetectedFooter now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a software version update rather than any change to study data or page content.SummaryDifference0.0%

Stay in the know with updates to Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.